GenderGP
GenderGP is a private London-based digital telehealth platform providing informed-consent gender-affirming care, including hormone therapy, consultations, and prescription referrals, to transgender and non-binary individuals globally via an online member Hub on a subscription model.
- Company typePrivate
- Founded2015
- HeadquartersLondon, United Kingdom
- Headcount51–100
- GTM typeB2C
- OfferingServices
What GenderGP does
GenderGP is a private digital healthcare platform founded in 2015 and headquartered in London that provides gender-affirming care to transgender and non-binary individuals on a global, direct-to-consumer basis. The service is delivered entirely through an online member Hub (hub.gendergp.com) where users complete consent check-ins, receive personalized 'Transition Packs' with prescription referrals, and access ongoing clinical and wellbeing support. The clinical model is informed-consent rather than gatekept, positioning access in approximately three weeks against reported NHS preliminary-assessment waits of 5.5 years (and projected 15-year waits at current referral rates). The company also operates an AI-enabled member-facing companion called 'Genni', plus dedicated resource hubs for youth, healthcare professionals, pharmacies, and advocacy.
The product portfolio spans feminisation, masculinisation, and non-binary hormone therapy; puberty blockers; doctor, nurse, and psychology consultations; blood test ordering; injection training; and formal documentation (diagnosis letters, gender marker letters, surgery and fertility referrals). Revenue is generated primarily through a one-off £220 setup fee plus a £30 monthly membership subscription (billed every 28 days), with additional prescription referral fees from £5 per month and paid-for consultations. The platform operates under an informed-consent clinical model and follows WPATH and other international guidelines. Distribution is exclusively digital, with prescription fulfillment routed through partner pharmacies and pathology laboratories, and care coordination extended via NHS GP shared-care agreements.
GenderGP serves customers primarily in the United Kingdom, with a US launch in November 2025 across an initial eight states and stated nationwide expansion plans, and a stated international footprint covering Ireland, Australia, and Brazil (with services unavailable in Singapore). The company has supported over 20,000 members through transition since founding, holds a 4.1/5 Trustpilot rating (683 reviews) and 4.2-star Google rating, and employs 51-100 staff. It is not publicly listed, no parent company or funding rounds are disclosed in available materials, and ownership structure is not publicly detailed.
GenderGP firmographics
Firmographics- Name
- GenderGP
- Legal name
- GenderGP
- Website
- https://gendergp.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- GenderGP is a private London-based digital telehealth platform providing informed-consent gender-affirming care, including hormone therapy, consultations, and prescription referrals, to transgender and non-binary individuals globally via an online member Hub on a subscription model.
- Ownership category
- akta.pro rank
GenderGP industry classification
Industry- Product category
- Gender-Affirming Telehealth
- NAICS
- Offices of Physicians, Mental Health Specialists (621112)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
- akta.pro secondary industry
- Gender-Affirming Endocrine Care (HLAKADAM)
Keywords
Where GenderGP is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
GenderGP business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Monthly Membership Subscription: Members pay £30 monthly (billed every 28 days) for ongoing access to prescription referrals, personal Hub management, and automated Transition Pack updates. This is the primary recurring revenue stream.
- Initial Setup Fee: One-time £220 initial fee covering consent check-in, ID verification, clinical review, and initial Transition Pack creation. Additional costs apply for those under 16.
- Prescription Referral Fee: From £5 per month for prescription referrals. Medication costs are paid directly to the pharmacy separately and vary by treatment type.
- Additional Consultations and Services: Optional paid services including doctor consultations, nurse consultations, psychology sessions, blood test orders, injection training, surgery referrals, fertility referrals, and gender marker letters.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Monthly | One-off initial setup covering consent, verification, and Transition Pack |
| Subscription | Monthly | Ongoing monthly membership with prescription access and Hub management |
| Subscription | Monthly | Monthly prescription referral fee for medication processing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
GenderGP product offering
Product offeringCore offering
GenderGP is a private digital healthcare provider that delivers gender-affirming care to transgender and non-binary individuals via an online member Hub. Its core offering combines informed-consent consultations, personalized hormone therapy prescriptions (oestrogen, testosterone, progesterone, puberty blockers), and ongoing clinical support, supplemented by letters, surgery referrals, blood tests, and mental health services. Members pay a £220 one-off setup fee plus £30 monthly membership, with medications fulfilled through partner pharmacies.
Product overview
GenderGP is a digital gender-affirming healthcare platform offering a comprehensive suite of services for transgender and non-binary individuals. The core offering consists of private online consultations, hormone therapy prescriptions (feminisation, masculinisation, and non-binary pathways), and ongoing medical support delivered through an informed consent model. Key platform components include The Hub (member dashboard with prescription management), the Transition Pack (personalised medication roadmap), and Genni (digital companion feature). Supplementary services span doctor and nurse consultations, psychology/counselling sessions, formal documentation (diagnosis letters, gender marker letters, surgery referrals), blood test ordering, injection training, and fertility referrals. The service extends to specialised resource portals including the Youth Hub, Medical Hub (for healthcare professionals), Pharmacy Hub, and Advocacy Hub. Membership is structured with a one-off £220 initial setup fee plus £30 monthly subscription. The platform follows WPATH and international clinical guidelines.
Differentiator
Problem solved
Functional benefit
Brands
- Genni: Digital companion/AI assistant designed to listen, support, and help users feel heard in their gender journey.
Quantifiable outcome
- Access to prescription referrals in as little as 3 weeks (vs 5.5+ years NHS wait)
- +2 more outcomes
Companies that use GenderGP
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
GenderGP technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
GenderGP partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core.
- LGBT FoundationcoreLGBT Foundation echoed GenderGP's concerns about CQC guidance and recommended the CQC engage with those representing trans patients. Both organisations requested CQC review community feedback on guidance affecting shared care.
- Women and Equalities Committee (WEC)coreGenderGP liaises with the UK Women and Equalities Committee as part of its advocacy work to ensure transgender and gender diverse people can access the best standards of health and wellbeing care.
- Nursing and Midwifery Council (NMC)coreGenderGP engages with the NMC as part of advocacy efforts to improve guidance for nurses and midwives supporting transgender patients.
- British Menopause Society (BMS)corePartnership with BMS for guidance on hormone-related healthcare and best practices in gender-affirming hormone therapy.
- Care Quality Commission (CQC)coreGenderGP advocates with the UK CQC to issue guidance ensuring every transgender and gender diverse person can access support and treatment without discrimination or gatekeeping. GenderGP wrote to CQC Chief Executive expressing concerns about guidance affecting shared care arrangements.
- Irish College of General Practitioners (ICGP)coreGenderGP actively advocates alongside other organisations for the ICGP to issue guidance ensuring every transgender and gender diverse person in Ireland can access support and treatment without discrimination or gatekeeping. Currently in dialog with ICGP regarding improving trans healthcare access in Ireland.
- Royal College of General PractitionerscoreDr Jonathan Leach, RCGP Honorary Secretary, confirmed that sharing of information between GPs and private providers should be no different than between NHS colleagues, supporting the shared care model.
- Network of Gender Specialists and DoctorscoreGenderGP works with a carefully selected network of doctors trained, qualified, and passionate about gender-affirming care. These specialists provide expert guidance via formal treatment summaries that GPs can follow.
- Partner PharmaciescoreCollaborative relationships with pharmacies that dispense medication to GenderGP patients. Pharmacies provide services under their own terms and conditions with independent licensing and regulation.
- Partner Pathology LaboratoriescoreCollaborative relationships with pathology laboratories for blood testing services. Laboratories provide services under their own terms and conditions with independent licensing and regulation.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
GenderGP competitors and assessment
Company assessmentBroad incumbents
- Hims & Hers Health: Large US telehealth platform offering a broad portfolio including testosterone and women's hormone products. Overlaps with GenderGP on prescription-based digital care but is not a gender-affirming specialist.
- Maven Clinic: Virtual care platform focused on women's and family health, including fertility, pregnancy and mental health. Comparable digital-first care delivery and patient engagement model, broader scope.
- Teladoc Health: Global leader in virtual care offering general telehealth, mental health and chronic condition management. Relevant as large-scale incumbent that could enter GenderGP's niche through partnerships or acquisitions.
- Livi (Kry): Major European digital healthcare provider offering GP consultations via app in UK and several EU markets. Broad incumbent in telehealth with comparable delivery model but general-practice focus.
- Zava: European online clinic offering remote consultations and prescriptions across multiple conditions. Comparable digital-first primary care model operating in similar geographies (UK, Germany, France, Ireland).
Direct peers
- Folx Health: US DTC virtual care provider for the LGBTQIA+ community offering hormone therapy, sexual health, mental health and primary care. Competes head-on with GenderGP for US gender-affirming care demand.
- Plume: US-based direct-to-consumer telehealth platform providing gender-affirming hormone therapy, lab work, and letters to transgender adults. Closest direct competitor to GenderGP in model, customer and clinical offering.
- Queerly Health: Telehealth platform offering affirming mental health and gender care to LGBTQ+ adults. Smaller emerging player with overlapping DTC gender-affirming focus.
- Klinic: US telehealth provider specialising in gender-affirming care, hormone replacement therapy and sexual health. Directly comparable online HRT delivery model.
Emerging players
- Twentyeight Health: US virtual care platform offering contraception, sexual health and select hormone care to underserved women. Shares digital-first prescription model but narrower intersection with GenderGP's transgender focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
GenderGP social profiles
Digital presenceGenderGP financial estimates
Financial estimateRevenue estimate
Valuation estimate
GenderGP leadership team
Management profileNumber of profiles
Profiles6 records
GenderGP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GenderGP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GenderGP
What does GenderGP do?
GenderGP is a private digital healthcare provider that delivers gender-affirming care to transgender and non-binary individuals via an online member Hub. Its core offering combines informed-consent consultations, personalized hormone therapy prescriptions (oestrogen, testosterone, progesterone, puberty blockers), and ongoing clinical support, supplemented by letters, surgery referrals, blood tests, and mental health services. Members pay a £220 one-off setup fee plus £30 monthly membership, with medications fulfilled through partner pharmacies.
Is GenderGP a public or private company?
GenderGP is a private company. It is classified as unknown and is currently operating.
When was GenderGP founded?
GenderGP was founded in 2015. It employs 51 to 100 people.
Where is GenderGP based?
GenderGP is headquartered in London, United Kingdom, in the Europe region.
How does GenderGP make money?
Four revenue lines are on record. Monthly Membership Subscription is the primary driver. The others are initial Setup Fee, prescription Referral Fee and additional Consultations and Services.
Who are GenderGP's main competitors?
Broad incumbents on record are Hims & Hers Health, Maven Clinic, Teladoc Health, Livi (Kry) and Zava. Direct peers are Folx Health, Plume, Queerly Health and Klinic. Twentyeight Health is listed as an emerging player.
Does GenderGP have an API?
No public API is recorded for GenderGP.
What industry is GenderGP in?
GenderGP's product category is Gender-Affirming Telehealth. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLAKADAM, Gender-Affirming Endocrine Care. Its NAICS code is 621112 and its SIC code is 8011.